Biogen’s $200M expansion is another boost to NC’s growing biopharma sector
North Carolina’s gene and cell therapy magnet has attracted an investment from one of the state’s original biomanufacturers Biogen.
Read MorePosted by WRAL TechWire | Mar 4, 2021
North Carolina’s gene and cell therapy magnet has attracted an investment from one of the state’s original biomanufacturers Biogen.
Read MorePosted by WRAL TechWire | Jan 15, 2021
Meet Atsena Therapeutics – a clinical-stage gene therapy company headquartered in Durham that’s on a mission to reverse and prevent blindness.
Read MorePosted by WRAL TechWire | Jan 7, 2021
California gene therapy innovator Adverum Biotechnologies announced plans today to invest $83 million to establish a manufacturing site in Durham that will employ 202 people at an average salary of $93,762 when fully operational.
Read MorePosted by WRAL TechWire | Dec 17, 2020
Taysha is joining the fast-growing community of cutting-edge gene- and cell-therapy companies setting up shop in the Research Triangle, where decades of investment and workforce training have created a magnet for the discovery and manufacture of science’s game-changers in fighting some of humankind’s most fearsome maladies.
Read MorePosted by WRAL TechWire | Dec 17, 2020
Taysha Gene Therapies will add more than 200 jobs paying an average of some $120,000 as part of an expansion in Durham County. Here are the details.
Read MorePosted by WRAL TechWire | Dec 16, 2020
Atsena Therapeutics, a gene therapy startup backed by Durham-based Hatteras Ventures, has $55 million in new funding and is planning to expand its Triangle workforce.
Read MorePosted by WRAL TechWire | Nov 4, 2020
GeneVentiv Therapeutics, Inc., a gene therapy developer, announced a license agreement with the University of North Carolina at Chapel Hill for a patent-pending, gene therapy for hemophilia.
Read MorePosted by WRAL News | Oct 28, 2020
After sale to Bayer, gene therapy firm AskBio plans expansion and hiring, says its CEO in an exclusive interview with WRAL TechWire.
Read MorePosted by WRAL TechWire | Oct 27, 2020
Asklepios BioPharmaceutical (AskBio), a pioneering gene therapy company born in Chapel Hill 19 years ago and supported in its early years by the North Carolina Biotechnology Center, will be acquired by Bayer AG, Here’s a look at the deal and the company’s history.
Read More